Skip to main content
Fig. 2 | Trials

Fig. 2

From: The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial

Fig. 2

The secondary endpoints are illustrated. a Dimensions of a wart are the product of the largest diameter (mm) on an axis line (AL) of the wart and the largest diameter on a normal line of the AL. b The cross-sectional area of a wart is calculated from the pixel count of the digital image. c The number of clots observable through the surface of a wart is counted

Back to article page